Published in Science on February 25, 2000
Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med (2009) 3.68
Treatment of human disease by adeno-associated viral gene transfer. Hum Genet (2006) 1.84
FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci U S A (2001) 1.67
Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice. J Virol (2007) 1.41
Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proc Natl Acad Sci U S A (2001) 1.40
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques. J Virol (2005) 1.36
New pathophysiological insights and modern treatment of IBD. J Gastroenterol (2010) 1.31
Complement is an essential component of the immune response to adeno-associated virus vectors. J Virol (2008) 1.11
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol (2001) 1.11
Activation of neuronal NMDA receptors induces superoxide-mediated oxidative stress in neighboring neurons and astrocytes. J Neurosci (2012) 1.04
Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98
Breast cancer expresses functional NMDA receptors. Breast Cancer Res Treat (2009) 0.90
Replication competent helper functions for recombinant AAV vector generation. Gene Ther (2002) 0.87
Gene therapy in epilepsy. Epilepsia (2008) 0.87
Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size. Stroke (2013) 0.86
A nonproliferating parvovirus vaccine vector elicits sustained, protective humoral immunity following a single intravenous or intranasal inoculation. J Virol (2004) 0.84
Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants. Mol Ther (2015) 0.84
Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl(4)-induced hepatic fibrosis in mice. Mol Ther (2012) 0.83
NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment. Clin Pharmacol (2010) 0.82
Diagnostic and pathogenic significance of glutamate receptor autoantibodies. Arch Neurol (2008) 0.82
Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo. World J Gastroenterol (2005) 0.82
Current prospects and challenges for epilepsy gene therapy. Exp Neurol (2011) 0.80
Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy. Histochem Cell Biol (2016) 0.80
Genetic Manipulation of Brown Fat Via Oral Administration of an Engineered Recombinant Adeno-associated Viral Serotype Vector. Mol Ther (2016) 0.79
Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer. Mol Ther (2013) 0.79
Transient cytochalasin-D treatment induces apically administered rAAV2 across tight junctions for transduction of enterocytes. J Gen Virol (2008) 0.79
HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors. Neurobiol Dis (2012) 0.79
Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice. Psychopharmacology (Berl) (2008) 0.79
NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines. Clin Pharmacol (2015) 0.78
Therapeutic antibodies in stroke. Transl Stroke Res (2013) 0.77
Conantokin-G attenuates detrimental effects of NMDAR hyperactivity in an ischemic rat model of stroke. PLoS One (2015) 0.77
An Immunological Approach to Increase the Brain's Resilience to Insults. ISRN Neurosci (2014) 0.75
Neuroscience. New stroke treatment strategy explored. Science (2000) 0.75
Adeno-Associated Viral Vector Delivery to the Enteric Nervous System: A Review. Postdoc J (2015) 0.75
Protective immunity of rAd5/NR2B vaccine against concomitant aversiveness of spontaneous neuropathic pain following spinal nerve ligation injury. Int J Clin Exp Med (2015) 0.75
NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment. Clin Pharmacol (2017) 0.75
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 23.49
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (1992) 11.99
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A (1997) 6.92
Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol (1991) 6.30
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (2000) 5.55
The nucleotide sequence of the cloned rpoD gene for the RNA polymerase sigma subunit from E coli K12. Nucleic Acids Res (1981) 5.52
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet (1994) 5.49
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res (1995) 5.11
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Crystal structure of TFIID TATA-box binding protein. Nature (1992) 4.85
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell (2001) 4.58
A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J (1978) 4.23
Obesity-related glomerulopathy: an emerging epidemic. Kidney Int (2001) 3.98
Studies on Gonococcus infection. X. Pili and leukocyte association factor as mediators of interactions between gonococci and eukaryotic cells in vitro. Infect Immun (1975) 3.63
ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet (2000) 3.49
Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect Immun (1986) 3.44
An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem (2000) 3.44
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol (1992) 3.15
Phenotypic diversity and ecosystem functioning in changing environments: a theoretical framework. Proc Natl Acad Sci U S A (2001) 3.13
The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium. Mol Microbiol (1995) 3.11
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol (1997) 3.05
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis. Mol Microbiol (1991) 3.01
Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J Cell Biol (1994) 2.95
Signal transduction by the TCR for antigen. Curr Opin Immunol (2000) 2.87
Partial genetic characterization of West Nile virus strains, New York State, 2000. Emerg Infect Dis (2001) 2.82
mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol (1996) 2.78
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J Bacteriol (1993) 2.72
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71
Both lumenal and cytosolic gating of the aqueous ER translocon pore are regulated from inside the ribosome during membrane protein integration. Cell (1997) 2.71
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
The dynamics of cocirculating influenza strains conferring partial cross-immunity. J Math Biol (1997) 2.69
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (1995) 2.69
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science (1995) 2.68
The Baby Friendly Hospital Initiative in the U.S.: why so slow? Birth (1993) 2.67
Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell (1986) 2.65
The velo-cardio-facial syndrome: a clinical and genetic analysis. Pediatrics (1981) 2.64
Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59
The predictability of corneal flap thickness and tissue laser ablation in laser in situ keratomileusis. Ophthalmology (2000) 2.48
Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene (1994) 2.47
Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med (1995) 2.44
Shotgun optical maps of the whole Escherichia coli O157:H7 genome. Genome Res (2001) 2.43
Recognition of a peptide antigen by heat shock--reactive gamma delta T lymphocytes. Science (1990) 2.41
Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature (1997) 2.41
Anatomic consideration of C2 pedicle screw placement. Spine (Phila Pa 1976) (1996) 2.29
Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol (1993) 2.28
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med (1992) 2.26
Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol (1995) 2.25
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene (2001) 2.25
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate Cancer Prostatic Dis (2010) 2.24
PartsList: a web-based system for dynamically ranking protein folds based on disparate attributes, including whole-genome expression and interaction information. Nucleic Acids Res (2001) 2.23
Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int (2006) 2.23
Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities. Mol Cell Biol (2000) 2.21
Neonatal weight loss in breast and formula fed infants. Arch Dis Child Fetal Neonatal Ed (2003) 2.20
Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes (2001) 2.19
Integrated monitoring and analysis for early warning of patient deterioration. Br J Anaesth (2006) 2.17
Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations. Proc Natl Acad Sci U S A (1990) 2.16
Antidromic activation of neurones as an analytic tool in the study of the central nervous system. J Neurosci Methods (1981) 2.13
Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun (1993) 2.12
Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol (1998) 2.11
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Early results of primary Birmingham hip resurfacings. An independent prospective study of the first 230 hips. J Bone Joint Surg Br (2005) 2.08
Premedication with intravenous dexmedetomidine-midazolam suppresses fentanyl-induced cough. Ir J Med Sci (2012) 2.06
Completely diverted tube ileostomy compared with loop ileostomy for protection of low colorectal anastomosis: a pilot study. Colorectal Dis (2014) 2.06
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med (1973) 2.05
Beyond synexpression relationships: local clustering of time-shifted and inverted gene expression profiles identifies new, biologically relevant interactions. J Mol Biol (2001) 2.03
Evaluation of three hollow-fiber membrane oxygenators without integrated arterial filters for neonatal cardiopulmonary bypass. Perfusion (2011) 2.02
Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost (2007) 2.02
Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience (2004) 2.02
Ribose facilitates thallium-201 redistribution in patients with coronary artery disease. J Nucl Med (1991) 2.00
Is thoracolumbar fascia injury the cause of residual back pain after percutaneous vertebroplasty? A prospective cohort study. Osteoporos Int (2014) 1.99
Establishing ongoing quality assurance in a retinal screening programme. Diabet Med (2006) 1.98
Clomiphene citrate-induced perturbations during meiotic maturation and cytogenetic abnormalities in mouse oocytes in vivo and in vitro. Fertil Steril (2000) 1.97
The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol (1996) 1.97
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science (1998) 1.93
Autogenetic inhibition of motoneurones by impulses in group Ia muscle spindle afferents. J Physiol (1979) 1.92
Injecting drug use and HIV infection in southwest China. AIDS (1994) 1.91
The cotranslational integration of membrane proteins into the phospholipid bilayer is a multistep process. Cell (1996) 1.88
New materials in hydrothermal synthesis. Acc Chem Res (2001) 1.87
San Diego suicide study. I. Young vs old subjects. Arch Gen Psychiatry (1986) 1.86
Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology (2001) 1.84
Proportional hazards model with random effects. Stat Med (2000) 1.83
A giant outburst two years before the core-collapse of a massive star. Nature (2007) 1.82
Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med (1998) 1.79
Mild hypothermia via selective head cooling as neuroprotective therapy in term neonates with perinatal asphyxia: an experience from a single neonatal intensive care unit. J Perinatol (2006) 1.79
Variables influencing end-of-life care in children and adolescents with cancer. J Pediatr Hematol Oncol (2001) 1.78
The sinus nerve and baroreceptor input to the medulla of the cat. J Physiol (1975) 1.76
An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A (1998) 1.76
Immune responses to AAV in a phase I study for Canavan disease. J Gene Med (2006) 1.74